Chembio Diagnostics lost 4% in pre-market trade April 14, 2014 on BioPharma, Consumer Cyclicals, Diversified Financial, Macro Markets, Software & Services by Robert Fuller Chembio Diagnostics (CEMI) reported that it is finishing the agreement of distribution of one of its tests in the U.S.
